EAM
IRWD icon

EverPoint Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

EverPoint Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-597,000
Closed -$6.54M – 456
2016
Q2 		$6.54M Buy
+597,000
New +$5.83M 0.13% 198
2015
Q2 		– Sell
-358,200
Closed -$4.8M – 515
2015
Q1 		$4.8M Buy
+358,200
New +$4.7M 0.09% 290

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EverPoint Asset Management's IRWD Position: Q4 2016 in Review

EverPoint Asset Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 57% in Q4 2016, selling an estimated $16.2M and leaving 985,050 shares worth $12.6M. The position accounts for 0.23% of the portfolio, ranked #118.

EverPoint Asset Management first reported a position in IRWD in Q2 2014 and has held it in 11 quarters since. The position peaked at $32.7M in Q2 2016. 163 funds tracked by Wall St. Rank hold IRWD as of Q4 2016.

  • EverPoint Asset Management held 985,050 shares of Ironwood Pharmaceuticals worth $12.6M as of Q4 2016.
  • EverPoint Asset Management sold 1,283,550 Ironwood Pharmaceuticals shares in Q4 2016, an estimated $16.2M.
  • Ironwood Pharmaceuticals made up 0.23% of EverPoint Asset Management's portfolio in Q4 2016, its #118 holding.
  • EverPoint Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2014 and has held it in 11 quarters since.
  • EverPoint Asset Management's Ironwood Pharmaceuticals position peaked at $32.7M in Q2 2016.
  • 163 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.